歐洲的糖尿病治療藥物市場 是由出版商Frost & Sullivan在2011年09月所出版的。
這份英文市場調查報告書包含151 Pages 價格從美金6500起跳。
本報告提供歐洲的糖尿病治療藥物市場相關整體分析，歐洲各國的市場及技術趨勢，胰島素和以兩種口服的抗糖尿病藥物為中心的產品概要，各國法規趨勢，新興治療方法等資料彙整，為您概述為以下內容。
第1章 執行摘要
第2章 簡介
第3章 歐洲的糖尿病治療藥物市場
- 簡介
- 市場概要
- 產業課題
- 推動市場因素和阻礙因素
- 市場工程評量
- 收益預測
- 胰島素市場的市場工程評量
- 胰島素市場收益預測
- 口服抗糖尿病藥物的市場工程評量
- 口服抗糖尿病藥物市場收益預測
- 市場趨勢與分析
第4章 競爭及市場佔有率分析
第5章 歐洲的糖尿病治療藥物市場各地區分析
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 荷比盧三國
- 北歐各國
第6章 相關法規指南
第7章 糖尿病市場上新興治療方法
第8章 結論與策略性降低
第9章 產業參與企業資料庫
第10章 附錄
第11章 關於Frost＆Sullivan
圖表一覽
Abstract
The research study aims to thoroughly assess and analyse the diabetes
therapeutics market, market and technology trends, in European countries and
provide strategic recommendations for the success of the market participants.
Diabetes is the fastest growing market in the pharmaceutical industry. This
study is focussed on two segments Insulin and Oral Antidiabetics. The insulin
market is dominated by modern insulins and analogues. New therapeutic classes
of drugs are a major contributor in the Oral Antidiabetics segment.
Table of Contents
Executive Summary
- Objective and Scope
- Market Overview
- Market Segmentation
- Industry Challenges
- Market Drivers and Restraints
- Research Methodology
Introduction
- Introduction to Diabetes
- Diabetes Complications and Symptoms
Epidemiology
- Worldwide Diabetes Overview
- Diabetes in Europe
- Prevalence of Diabetes (Age 20-79 Years) in Europe
- Percentage Prevalence of Diabetes (Age 20-79 Years) in Europe
- Europe's Comparative Prevalence of Diabetes with World (Age 20-79 Years)
- Incidence Type 1 Diabetes in Children Europe (2010)
European Diabetes Therapeutics Market
- Market Overview
- Industry Challenges
- Market Drivers and Restraints
- Market Engineering Measurements
- Revenue Forecasts
- vRevenue Forecasts and Market Engineering Measurements: Insulin and Oral
Antidiabetics Market
- Market Engineering Measurements: Insulin Market (Europe)
- Revenue Forecasts: Insulin Market (Europe)
- Market Engineering Measurements: Oral Antidiabetics Market (Europe)
- Revenue Forecasts: Oral Antidiabetics Market (Europe)
Market Trends and Analysis: Insulin and Oral Antidiabetics Market
- Insulin Market Analysis
- Oral Antidiabetics Market Analysis
- Diabetes Therapeutics: Roadmap of Drug Adoption
- Oral Antidiabetics - Physician's Perception
Competitive Analysis
- Competitive Structure
- Competitive Analysis: Selected Key Market Participants
- Insulin: Key Product Analysis
- Oral Antidiabetics: Key Product Analysis
- Competitive Landscape: Victoza Versus Exenatide
- Key Alliances
Market Share Analysis
- Global Diabetes Therapeutics Market
- Insulin Market
- Modern Insulin Market
- Oral Antidiabetics Market
Regional Analysis of European Diabetes Therapeutics Market: The UK Diabetes Therapeutics Market
- Diabetes in The United Kingdom
- Market Engineering Measurements
- Revenue Forecasts (The United Kingdom)
German Diabetes Therapeutics Market
- Diabetes in Germany
- Market Engineering Measurements
- Revenue Forecasts (Germany)
French Diabetes Therapeutics Market
- Diabetes in France
- Market Engineering Measurements
- Revenue Forecasts (France)
Italian Diabetes Therapeutics Market
- Diabetes in Italy
- Market Engineering Measurement
- Revenue Forecasts (Italy)
Spanish Diabetes Therapeutics Market
- Diabetes in Spain
- Market Engineering Measurements
- Revenue Forecasts (Spain)
Benelux Diabetes Therapeutics Market
- Diabetes in Benelux
- Market Engineering Measurements
- Revenue Forecasts (Benelux)
Scandinavian Diabetes Therapeutics Market
- Diabetes in Scandinavia
- Market Engineering Measurements
- Revenue Forecasts (Scandinavia)
Regulatory Guidelines
- The EU Framework Approach Towards Diabetes
- Guidelines: Oral Therapy
- Guidelines: Insulin Therapy
- Diabetes Regulatory Policy: The United Kingdom
- Diabetes Regulatory Policy: Germany
- Diabetes Regulatory Policy: France
- Diabetes Regulatory Policy: Italy
- Diabetes Regulatory Policy: Spain
- Diabetes Regulatory Policy: Belgium
- Diabetes Regulatory Policy: The Netherlands
- Diabetes Regulatory Policy: Luxembourg
- Diabetes Regulatory Policy: Denmark
- Diabetes Regulatory Policy: Sweden
- Diabetes Regulatory Policy: Finland
Emerging Therapies in the Diabetes Therapeutics Market
- Disease Management for Diabetes Therapeutics
- Disease Management for Glycaemic Control
Product Profiling - Current Diabetes Products in The Market
- Type 1 Diabetes: Key Products in Europe
- Type 2 Diabetes: Key Products in Europe
- Key Patent Expiries and Expected New Drug Launches
Pipeline Analysis
Conclusions and Strategic Recommendations
Database of Key Industry participants
Appendix
- New Cases of Diabetes
- Prevalence of Diabetes
- Prevalence Percent of Diabetes
- Total Healthcare Expenditure
- Abbreviations
About Frost & Sullivan
List of Figures
- Diabetes Therapeutics Market: Diabetes Epidemiology (Europe), 2010 and 2030
- Diabetes Therapeutics Market: Prevalence of Diabetes in the Age Group of
20-79 Years (Europe), 2010 and 2030
- Diabetes Therapeutics Market: Rate of Diabetes Prevalence in the Age Group
of 20-79 Years (Europe), 2010 and 2030
- Diabetes Therapeutics Market: Comparative Prevalence Rate of Diabetes with
World in the Age Group of 20-79 (Europe), 2010 and 2030
- Diabetes Therapeutics Market: Diabetes Type 1 Incidence (Europe), 2010
- Diabetes Therapeutics Market: Revenue Forecasts (Europe), 2007-2017
- Insulin Market: Revenue Forecasts (Europe), 2007-2017
- Oral Antidiabetics Market: Revenue Forecasts (Europe), 2007-2017
- Diabetes Therapeutics Market: Competitive Structure (Europe), 2010
- Diabetes Therapeutics Market: Key Alliances (Europe), 2010
- Diabetes Therapeutics Market: Diabetes Epidemiology (The United kingdom),
2010 and 2030
- Diabetes Therapeutics Market: Revenue Forecasts (The United kingdom),
2007-2017
- Diabetes Therapeutics Market: Diabetes Epidemiology (Germany), 2010 and
2030
- Diabetes Therapeutics Market: Revenue Forecasts (Germany), 2007-2017
- Diabetes Therapeutics Market: Diabetes Epidemiology (France), 2010 and 2030
- Diabetes Therapeutics Market: Revenue Forecasts (France), 2007-2017
- Diabetes Therapeutics Market: Diabetes Epidemiology (Italy), 2010 and 2030
- Diabetes Therapeutics Market: Revenue Forecasts (Italy), 2007-2017
- Diabetes Therapeutics Market: Diabetes Epidemiology (Spain), 2010 and 2030
- Diabetes Therapeutics Market: Revenue Forecasts (Spain), 2007-2017
- Diabetes Therapeutics Market: Diabetes Epidemiology (Benelux), 2010 and
2030
- Diabetes Therapeutics Market: Revenue Forecasts (Benelux), 2007-2017
- Diabetes Therapeutics Market: Diabetes Epidemiology (Scandinavia), 2010
and 2030
- Diabetes Therapeutics Market: Revenue Forecasts (Scandinavia), 2007-2017
- Decision Support Database: New Cases of Diabetes (Western Europe),
2002-2012
- Decision Support Database: Prevalence of Diabetes (Western Europe),
2002-2012
- Decision Support Database: Prevalence Percent of Diabetes (Western
Europe), 2002-2012
- Decision Support Database: Total Healthcare Expenditure (Western Europe),
2004-2014
List of Charts
- Diabetes Therapeutics Market: Market Segmentation (Europe), 2010
- Diabetes Therapeutics Market: Industry Challenges (Europe), 2011-2017
- Diabetes Therapeutics Market: Market Drivers and Restraints (Europe),
2011-2017
- Diabetes Therapeutics Market: Introduction to Diabetes (Europe), 2010
- Diabetes Therapeutics Market: Prevalence of Diabetes in the Age Group of
20-79 Years (Europe), 2010 and 2030
- Diabetes Therapeutics Market: Rate of Diabetes Prevalence in the Age Group
of 20-79 Years (Europe), 2010 and 2030
- Diabetes Therapeutics Market: Comparative Prevalence Rate of Diabetes with
World in the Age Group of 20-79 (Europe), 2010 and 2030
- Diabetes Therapeutics Market: Industry Challenges (Europe), 2011-2017
- Diabetes Therapeutics Market: Market Drivers and Restraints (Europe),
2011-2017
- Diabetes Therapeutics Market: Diabetes Health Expenditure Per Person
(Europe), 2010
- Diabetes Therapeutics Market: Market Engineering Measurements (Europe),
2010
- Diabetes Therapeutics Market: Revenue Forecasts (Europe), 2007-2017
- Insulin Market: Market Engineering Measurements (Europe), 2010
- Insulin Market: Revenue Forecasts (Europe), 2007-2017
- Oral Antidiabetics Market: Market Engineering Measurements (Europe), 2010
- Oral Antidiabetics Market: Revenue Forecasts (Europe), 2007-2017
- Diabetes Therapeutics Market: Roadmap of Drug Adoption (Europe), 1920-2000
- Diabetes Therapeutics Market: Roadmap of Drug Adoption (Europe), 2000-2010
- Oral Antidiabetics Market: Physician's Perception (Europe), 2010
- Oral Antidiabetics Market: Percent of Revenues by Region for GLP-1
Analogue (World), 2010
- Oral Antidiabetics Market: Per cent of Revenues for Victoza Versus
Exenatide (Europe), 2009 and 2010
- Diabetes Therapeutics Market: Company Market Share by Revenues (World),
2010
- Insulin Market: Percent of Insulin Types by Revenues (Europe), 2010
- Insulin Market: Company Market Share by Revenues (Europe), 2010
- Insulin Market: Company Market Share by Revenues of Modern Insulin
(Europe), 2010
- Oral Antidiabetics Market: Company Market Share by Revenues of Therapeutic
Class (Europe), 2010
- Diabetes Therapeutics Market: Diabetes Prevalence by Age Groups (The
United Kingdom), 2010 and 2030
- Diabetes Therapeutics Market: Diabetes Prevalence by Gender Ratio (The
United Kingdom), 2010 and 2030
- Diabetes Therapeutics Market: Market Engineering Measurements (The United
Kingdom), 2010
- Diabetes Therapeutics Market: Revenue Forecasts (The United Kingdom),
2007-2017
- Diabetes Therapeutics Market: Diabetes Prevalence by Age Groups (Germany),
2010 and 2030
- Diabetes Therapeutics Market: Diabetes Prevalence by Gender Ratio
(Germany), 2010 and 2030
- Diabetes Therapeutics Market: Market Engineering Measurements (Germany),
2010
- Diabetes Therapeutics Market: Revenue Forecasts (Germany), 2007-2017
- Diabetes Therapeutics Market: Diabetes Prevalence by Age Groups (France),
2010 and 2030
- Diabetes Therapeutics Market: Diabetes Prevalence by Gender Ratio
(France), 2010 and 2030
- Diabetes Therapeutics Market: Market Engineering Measurements (France),
2010
- Diabetes Therapeutics Market: Revenue Forecasts (France), 2007-2017
- Diabetes Therapeutics Market: Diabetes Prevalence by Age Groups (Italy),
2010 and 2030
- Diabetes Therapeutics Market: Diabetes Prevalence by Gender Ratio (Italy),
2010 and 2030
- Diabetes Therapeutics Market: Market Engineering Measurements (Italy), 2010
- Diabetes Therapeutics Market: Revenue Forecasts (Italy), 2007-2017
- Diabetes Therapeutics Market: Diabetes Prevalence by Age Groups (Spain),
2010 and 2030
- Diabetes Therapeutics Market: Diabetes Prevalence by Gender Ratio (Spain),
2010 and 2030
- Diabetes Therapeutics Market: Market Engineering Measurements (Spain), 2010
- Diabetes Therapeutics Market: Revenue Forecasts (Spain), 2007-2017
- Diabetes Therapeutics Market: Diabetes Prevalence by Age Groups (Benelux),
2010 and 2030
- Diabetes Therapeutics Market: Diabetes Prevalence by Gender Ratio
(Benelux), 2010 and 2030
- Diabetes Therapeutics Market: Market Engineering Measurements (Benelux),
2010
- Diabetes Therapeutics Market: Revenue Forecasts (Benelux), 2007-2017
- Diabetes Therapeutics Market: Diabetes Prevalence by Age Groups
(Scandinavia), 2010 and 2030
- Diabetes Therapeutics Market: Diabetes Prevalence by Gender Ratio
(Scandinavia), 2010 and 2030
- Diabetes Therapeutics Market: Market Engineering Measurements
(Scandinavia), 2010
- Diabetes Therapeutics Market: Revenue Forecasts (Scandinavia), 2007-2017
- Diabetes Therapeutics Market: Key Patent Expiries and New Drug Launches
(Europe), 2010-2018
|
